Coenzyme Q10 therapy in current clinical practice

Abhishek Soni, Monica Verma, Vivek Kaushal, Veena S. Ghalaut

Abstract


Coenzyme Q10 (CoQ10) is a naturally occurring, lipid soluble, essential compound and is also known as ubiquinone. CoQ10 acts as an intermediate of the electron transport chain situated in membrane of mitochondria and vital for ATP production and cellular respiration. CoQ10 also serves as an intercellular antioxidant. All the clinical use of CoQ10 are based upon these two functions. CoQ10 levels are altered in a number of oncological as well as non-oncological diseases. Furthermore, recent data indicate that CoQ10 has an impact on the expression of many genes involved in metabolism, cellular transport, transcription control, and cell signaling, making CoQ10 a potent gene regulator. CoQ10 supplementation is useful in diseases associated with CoQ10 deficiency which includes primary and secondary CoQ10 deficiencies, fibromyalgia, diabetes mellitus, mitochondrial diseases, neurodegenerative diseases, cardiovascular disease, cancer, male infertility and periodontal disease. Clinical presentations of severe CoQ10 deficiency include severe infantile multisystemic disease, encephalomyopathy, isolated myopathy cerebellar ataxia and Leigh syndrome with growth retardation. Oral CoQ10 administration can correct CoQ10 deficiency since it increases CoQ10 tissue levels. CoQ10 therapy has no serious side effects in humans and new formulations have been developed that increase CoQ10 absorption and tissue distribution. Future trends involving CoQ10 in many diseases needs more clinical trials for better understanding of CoQ10 efficacy.


Keywords


CoQ10, Oxidation, Antioxidant, Cancer

Full Text:

PDF

References


Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, Vega AF, Mata M, Pavón AD, et al. Coenzyme Q10 therapy. Mol Syndromol. 2014;5:187-97.

Lesser GJ, Case D, Stark N, Williford S, Giguere J, Garino LA, et al. A Randomized double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment related fatigue in newly diagnosed patients with breast cancer. Support Oncol. 2013 Mar;11(1):31-42.

Bahar M, Khaghani S, Pasalar P, Paknejad M, Khorramizadeh MR, Mirmiranpour H, et al. Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model. Nutr J. 2010;9:62.

Overvad K, Diamant B, Holm L, Hùlmer G, Mortensen SA, Stender S. Coenzyme Q10 in health and disease. Eur J Clin Nutr. 1999;53:764-70.

Schweikert EM, Devarajan A, Witte I, Wilgenbus P, Amort J, Forstermann U, et al. PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death Differentiat. 2012;19:1549-60.

Cooney RV, Dai Q, Gao YT, Chow WH, Franke AA, Shu XO, et al. Low plasma coenzyme Q10 levels and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1124-30.

Conklin KA. Cancer chemotherapy and antioxidants. American Society for Nutritional Sciences. J Nutr. 2004;134:3201S-4S.

Brea-Calvo G, Rodríguez-Hernández A, Fernández-Ayala DJ, Navas P, Sánchez-Alcázar JA. Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines. Free Radic Biol Med. 2006 Apr;40(8):1293-302.

Chai W, Cooney RV, Franke AA, Shvetsov YB, Caberto CP, Wilkens LR, at al. Plasma Coenzyme Q10 levels and postmenopausal breast cancer risk: the multi-ethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2351-6.

Folkers K, Osterborg A, Nylander M, Morita M, Mellstedt H. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun. 1997;234:296-9.

Jolliet P, Simon N, Barre J, Pons JY, Boukef M, Paniel BJ, et al. Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences. Int J Clin Pharmacol Ther. 1998;36:506-9.

Palan PR, Connell K, Ramirez E, Inegbenijie C, Gavara RY, Ouseph JA, et al. Effects of menopause and hormone replacement therapy on serum levels of coenzyme Q10 and other lipid-soluble antioxidants. Biofactors. 2005;25:61-6.

Karlsson J, Diamant B, Theorell H, Folkers K. Uniquinone and alpha tocopherol in plasma; means of translocation or depot. Clin Invest. 1993;71(Suppl):S84-91.

Greenlee H, Shaw J, Lau YKI, Naini A, Maurer M. Effect of coenzyme Q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Integr Cancer Ther. 2012 Sep;11(3):10.1177/1534735412439749.

Yuvaraj S, Premkumar VG, Shanthi P, Vijayasarathy K, Gangadaran SG, Sachdanandam P. Effect of coenzyme Q(10), riboflavin and niacin on tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles. Breast Cancer Res Treat. 2009 Mar;114(2):377-84.

Premkumar VG, Yuvaraj S, Vijayasarathy K, Gangadaran SGD, Sachdanandam P. Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 Levels in breast cancer patients undergoing tamoxifen therapy. Biol Pharm Bull. 2007;30(2):367-70.

Sachdanandam P. Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing tamoxifen therapy. Biofactors. 2008;32(1-4):151-9.

Chai W, Cooney RV, Franke AA, Caberto CP, Wilkens LR, Marchand LL, et al. Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2011;20:708-10.

Hoenjet KM, Dagnelie PC, Delaere KP, Wijckmans NE, Zambon JV, Oosterhof GO. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study. Eur Urol. 2005 Apr;47(4):433-9.

Quiles JL, Farquharson AJ, Ramírez-Tortosa MC, Grant I, Milne L, Huertas JR, et al. Coenzyme Q differentially modulates phospholipid hydroperoxide glutathione peroxidase gene expression and free radicals production in malignant and non-malignant prostate cells. Biofactors. 2003;18(1-4):265-70.

Palan PR, Mikhail MS, Shaban DW, Romney SL. Plasma concentrations of coenzyme Q10 and tocopherols in cervical intraepithelial neoplasia and cervical cancer. Eur J Cancer Prev. 2003 Aug;12(4):321-6.

Rusciani L, Proietti I, Paradisi A, Rusciani A, Guerriero G, Mammone A, et al. Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up. Melanoma Res. 2007 Jun;17(3):177-83.

Rusciani L, Proietti I, Rusciani A, Paradisi A, Sbordoni G, Alfano C, et al. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol. 2006 Feb;54(2):234-41.

Cobanoglu U, Demir H, Cebi A, Sayır F, Alp HH, Akan Z, et al. Lipid Peroxidation, DNA damage and coenzyme Q10 in lung cancer patients - markers for risk assessment? Asian Pac J Cancer Prev. 2011;12:1399-403.

Tharappel JC, Lehmler HJ, Srinivasan C, Robertson LW, Spear BT, Glauert HP. Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3’,4,4’-tetrachlorobiphenyl (PCB-77). Food Chem Toxicol. 2008 Nov;46(11):3467-74.

Hertz N, Lister RE. Improved survival in patients with end-stage cancer treated with coenzyme Q10 and other antioxidants: a pilot study. J Int Med Res. 2009;37:1961-71.

Sieswerda E, van Dalen EC, Postma A, Cheuk DK, Caron HN, Kremer LC. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst Rev. 2011 Sep;(9):CD008011.

Forgionne GA, Hoenjet KM, Dagnelie PC, Delaere KP, Wijckmans NE, Zambon JV, et al. Bovine cartilage, coenzyme Q10, and wheat grass therapy for primary peritoneal cancer. J Altern Complement Med. 2005 Feb;11(1):161-5.

Malm C, Svensson M, SjoÈberg B, Ekblom B, SjoÈdin B. Supplementation with ubiquinone-10 causes cellular damage during intense exercise. Acta Physiol Scand. 1996;157:511-2.

Witting PK, Pettersson K, Letters J, Stocker R. Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic Biol Med. 2000;29:295-305.

Hargreaves IP, Duncan AJ, Heales SJ, Land JM: The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. Drug Saf. 2005;28:659-76.

Singh RB, Wander GS, Rastogi A, Shukla PK, Mittal A, Sharma JP, et al. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in-patients with acute myocardial infarction. Cardiovasc Drugs Ther. 1998;12:347-53.

Pepe S, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL. Coenzyme Q10 in cardiovascular disease. Mitochondrion. 2007;7(suppl):S154-67.

Chello M, Mastroroberto P, Romano R, Castaldo P, Bevacqua E, Marchese AR. Protection by coenzyme Q10 of tissue reperfusion injury during abdominal aortic cross-clamping. J Cardiovasc Surg. 1996;37:229-35.

Hernandez-Ojeda J, Cardona-Munoz EG, Roman-Pintos LM, Troyo-Sanroman R, Ortiz- Lazareno PC, Cárdenas-Meza MA, et al. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study. J Diabetes Complication. 2012;26:352-8.

Shults CW, Flint Beal M, Song D, Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson’s disease. Exp Neurol. 2004;188:491-4.

Naia L, Ribeiro MJ, Rego AC. Mitochondrial and metabolic-based protective strategies in Huntington’s disease: the case of creatine and coenzyme Q. Rev Neurosci. 2011;23:13-28.

Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C, et al. Antioxidant treatment of patients with Friedreich ataxia: four-year follow- up. Arch Neurol. 2005;62:621-6.

Cordero MD, Cano-Garcia FJ, Alcocer-Gomez E, De Miguel M, Sanchez-Alcazar JA. Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q10 effect on clinical improvement. PLoS One. 2012;7:e35677.

Quinzii CM, Hirano M. Primary and secondary CoQ10 deficiencies in humans. Biofactors. 2011;37:361-5.

Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, et al. Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology. 2001;57:515-8.

Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, Shechter AL, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22:137-41.

Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of preeclampsia. Int J Gynaecol Obstet. 2009;105:43-5.

Tiano L, Busciglio J. Mitochondrial dysfunction and Down’s syndrome: is there a role for coenzyme Q10? Biofactors. 2011;37:386-92.